ABSTRACT
INTRODUCTION
Overeating and physical inactivity predispose to both conditions. Excess glucose, fructose and amino acids are converted to triglyceride (TG) in the liver via de novo lipogenesis, which pathway is increased in NAFLD [Lambert et al., 2014]. Alterations in gut microbiota in obesity increase gut permeability to bacterial components such as lipopolysaccharide (LPS), which may contribute to inflammation in both adipose tissue and the liver [Cani et al., 2014]. Overeating leads to adipose tissue expansion, hypoxia, increased fibrosis and cell death. Dead adipocytes are surrounded by macrophages, which produce cytokines such as tumor-necrosis alpha and chemokines such as monocyte chemoattractant protein-1. This impairs the ability of insulin to inhibit lipolysis i.e., inhibit release of free fatty acids (FFA) and leads to deficiency of the insulin sensitizing cytokine adiponectin. The latter two changes promote synthesis of intrahepatocellular TG. The ability of insulin to suppress glucose and very low density lipoprotein (VLDL) production is impaired resulting in mild hyperglycemia and hyperinsulinemia, hypertriglyceridemia (TG↑) and a low HDL cholesterol concentration (HDL chol↓). The fatty liver also overproduces many other factors such as the liver enzymes alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gammaglutamyltransferase (GGT), C-reactive protein (CRP) and coagulation factors [YakiJarvinen, 2014].
The liver is the site of production of two key components of the insulin resistance and metabolic syndrome (MetS), these are fasting serum glucose and verylow density lipoprotein (VLDL). In subjects with NAFLD attributable to being overweight and inactive ("Metabolic NAFLD") The aim of this prospective study is to assess the prevalence of insulin resistance in non-diabetic adult patients with non-alcoholic fatty liver disease and its relation with metabolic syndrome.
SUBJECTS & METHODS
This cross-sectional study was approved by the local ethical committee of the General Organization for Teaching Hospitals and Institutes (GOTHI). Informed consent was obtained from all subjects before the beginning of the study. Forty (40) patients with NAFLD were selected from patients attending the outpatient clinics of National Nutrition Institute (NNI) from August 2011 to August 2012 according to inclusion criteria. The patients included in the study were defined by the presence of sonographic criteria of fatty liver in abdominal ultrasound.
Exclusion Criteria
Patients excluded from the study were the following: 
CLINICAL &ANTHROPOMETRIC

EVALUATIONS:
All studied patients were subjected to full history and clinical examination with stress on features of chronic liver disease and alcohol intake.
Blood pressure measurements were obtained and systemic hypertension was defined as systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg on at least 2 consecutive measures.
Body height was measured to the nearest 0.1 cm. After an overnight fast of 12 hours, venous blood sample of 5ml. was collected from selected subjects for determination of different biochemical parameters. Two ml. of the blood sample were collected in EDTA tubes for plasma glucose concentration assay and plasma insulin level determination; 3 ml. were collected in plain tubes for separation of serum. Serum was rapidly separated by centrifugation. Separated serum was stored frozen at -20°C until analysis. 
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RESULTS
Demographic, metabolic and biochemical findings of the study population
The demographic, metabolic and biochemical findings of the study population are presented in (Table 1) .
Females constituted 57.5% of the study population versus males who were 42.5% of the NAFLD patients. Hypertension was seen in 55.5% of the subjects, while MetSe was diagnosed in 50% of the study population. Insulin resistance was recorded in 62.5% of the NAFLD patients.
We compared the demographic, metabolic and biochemical findings of the study population in both females and males (Table 2) . We found that prevalence of low HDL-cholesterol (82.6% vs 52.9%, respectively; p=0.043) was significantly higher in females compared to males. BMI was higher in females than in males but this increase was not statistically significant. On the other hand, TC and TG were higher among male subjects but this increase was not statistically significant, probably due to the small sample size. Subjects with NAFLD were divided into two subgroups: subjects with normal ALT levels (n=32) and subjects with elevated ALT levels (n=8) (ALT >31 U/L in females and ALT >37 U/L in males). (Table3). Female sex was predominant in the high ALT subgroup when compared to the normal ALT subgroup (62.5%vs.56.3% respectively).The prevalence of hypertension (62.5% vs.53.1%, respectively; p=0.634), metabolic syndrome (75% vs. 43.8% respectively; p=0.114), hypertriglyceridemia (25% vs.9.4%; respectively; p=0.232) and insulin resistance (75% vs. 59.4%, respectively; p=0.414) were not significantly different between the high ALT and the normal ALT subgroups.
The prevalence of elevated FBG (62.5%vs.9.4%, respectively; p=0.001) and low HDL (100%vs.62.5%, respectively; p=0.038) was significantly higher in the high ALT subgroup (Table  3) .
The patients were also divided into two subgroups according to the level of AST into patients with normal AST levels (n=35) and patients with high AST levels (n=5) (AST >31 U/L in females and AST >37 U/L in males). The prevalence of elevated FBG (60% vs.14.3%, respectively; p=0.017) was significantly higher in the high AST subgroup. Serum HDL cholesterol (32.4mg/dl vs.40.8 mg/dl respectively; p=0.021) was significantly lower in the high AST subgroup when compared to the normal AST subgroup (Table 4) .
The patients were also classified as insulin-resistant (n=25) and insulin-sensitive (n=15) according to the HOMA-IR value. Statistically significant differences were found between the insulinresistant and insulin-sensitive groups with regard to age (42.6 years vs.37.3 years, respectively; p=0.038), PPBG (111.1 mg/dl vs. 102.7 mg/dl, respectively; p=0.013), fasting insulin (15.9 µU/ml vs. 7.82 µU/ml, respectively; p=0.000) and HOMA-IR (3.45 vs. 1.6, respectively; p=0.000) ( Table  5) . Waist circumference, BMI and TG showed positive correlation with HOMA-IR while HDL showed negative correlation as shown in Figures 1, 2, 3 In our study, NAFLD patients with insulin resistance had significantly higher triglyceride levels compared with those without insulin resistance. This finding is consistent with Choi & Ginsberg, (2011) who suggested that IR is associated with increased hepatic assembly and secretion of VLDL and increased plasma TG as well as hepatic steatosis. This result agrees with the multiple logistic regression analysis done by Erkan et al., 2014 which demonstrated that sex, waist circumference, IR, and triglyceride levels were independently related to NAFLD in non-obese subjects.
In our study NAFLD patients were divided into two subgroups: subjects with normal ALT levels and subjects with elevated ALT levels (ALT >31 U/L in females and ALT >37 U/L in males). (Table2 There were some limitations to our study. Ultrasonography was utilized to detect fatty liver disease rather than a liver biopsy. Ultrasonography is currently the most widely utilized method for screening asymptomatic patients with elevated liver enzymes and suspected NAFLD. Nevertheless, ultrasonography cannot provide precise quantitative information about the degree of fat accumulation, or detect inflammation and fibrosis, and thus it cannot be utilized to diagnose NASH and hepatic fibrosis. However, we consider it unethical to perform liver biopsy for obese or overweight patients with evident fatty liver in ultrasound. In the future studies a precise and noninvasive method to detect the presence of NAFLD could replace or augment abdominal ultrasound like MRI.
Another limitation of our study was the relatively small sample size, however in this small number; IR was detected in most of the studied patients. Regarding NAFLD, being a corner disease, the small number examined cannot represent the general population and a greater sample size is recommended to be included in future studies.
CONCLUSION
In conclusion, this study found that in a non-diabetic cohort, NAFLD is associated with a high prevalence of obesity and MetS. We concluded that patients with NAFLD and MetS are more insulin resistant even in the absence of diabetes and a recommendation of a liver biopsy to evaluate for NASH may be reasonable in these patients. This knowledge may lead to more aggressive management of the MetS risk factors and may lead to improvement in patient's liver disease. Treatment may include weight loss through diet and exercise, which could improve several components of the MetS. 
REFERENCES
